These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 2113298

  • 41. Oxygenation effect of fluosol-DA on hypoxic tumor tissue and retention of PFCs in the tumor-bearing rats.
    Watanabe M, Okamoto H, Ohyanaqi H, Saitoh Y, Yano K, Tsuda Y, Ueda Y, Yokoyama K.
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):547-56. PubMed ID: 3140922
    [Abstract] [Full Text] [Related]

  • 42. The optimal combination of hyperthermia and carbogen breathing to increase tumor oxygenation and radiation response.
    Griffin RJ, Okajima K, Song CW.
    Int J Radiat Oncol Biol Phys; 1998 Nov 01; 42(4):865-9. PubMed ID: 9845112
    [Abstract] [Full Text] [Related]

  • 43. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
    Chaplin DJ, Horsman MR, Aoki DS.
    Br J Cancer; 1991 Jan 01; 63(1):109-13. PubMed ID: 1846549
    [Abstract] [Full Text] [Related]

  • 44. The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo.
    Teicher BA, Herman TS, Holden SA, Cathcart KN.
    Cancer Chemother Pharmacol; 1988 Jan 01; 21(4):286-91. PubMed ID: 3131033
    [Abstract] [Full Text] [Related]

  • 45. Optimization of perfluorochemical levels with radiation therapy in mice.
    Teicher BA, Herman TS, Jones SM.
    Cancer Res; 1989 May 15; 49(10):2693-7. PubMed ID: 2713854
    [Abstract] [Full Text] [Related]

  • 46. New high O2 carrying perfluorochemical emulsions and/or carbogen: reactions of a human tumor xenograft to irradiation.
    Thomas C, Lartigau E, Malaise EP, Guichard M.
    Int J Radiat Oncol Biol Phys; 1989 May 15; 16(5):1157-60. PubMed ID: 2497094
    [Abstract] [Full Text] [Related]

  • 47. Radiosensitization of two murine tumours with mild temperature hyperthermia and carbogen breathing.
    Griffin RJ, Okajima K, Ogawa A, Song CW.
    Int J Radiat Biol; 1999 Oct 15; 75(10):1299-306. PubMed ID: 10549607
    [Abstract] [Full Text] [Related]

  • 48. Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.
    Teicher BA, Herman TS, Tanaka J, Dezube B, Pardee A, Frei E.
    Cancer Chemother Pharmacol; 1991 Oct 15; 28(1):45-50. PubMed ID: 1904012
    [Abstract] [Full Text] [Related]

  • 49. Mild temperature hyperthermia combined with carbogen breathing increases tumor partial pressure of oxygen (pO2) and radiosensitivity.
    Griffin RJ, Okajima K, Barrios B, Song CW.
    Cancer Res; 1996 Dec 15; 56(24):5590-3. PubMed ID: 8971160
    [Abstract] [Full Text] [Related]

  • 50. Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy.
    Griffin RJ, Williams BW, Park HJ, Song CW.
    Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1516-22. PubMed ID: 15817358
    [Abstract] [Full Text] [Related]

  • 51. Improving the radiation response in a C3H mouse mammary carcinoma by normobaric oxygen or carbogen breathing.
    Grau C, Horsman MR, Overgaard J.
    Int J Radiat Oncol Biol Phys; 1992 Apr 01; 22(3):415-9. PubMed ID: 1735671
    [Abstract] [Full Text] [Related]

  • 52. Fluosol-DA in radiation therapy.
    Lustig RA, McIntosh NL.
    Prog Clin Biol Res; 1986 Apr 01; 211():29-38. PubMed ID: 3960931
    [No Abstract] [Full Text] [Related]

  • 53. Correlation between radiosensitivity, percentage hypoxic cells and pO2 measurements in one rodent and two human tumor xenografts.
    Thomas CD, Chavaudra N, Martin L, Guichard M.
    Radiat Res; 1994 Jul 01; 139(1):1-8. PubMed ID: 8016297
    [Abstract] [Full Text] [Related]

  • 54. Evaluation of nitrobenzimidazoles as hypoxic cell radiosensitizers.
    Wright J, Frank LR, Bush D, Harrison GH.
    Radiat Res; 1983 Jul 01; 95(1):187-96. PubMed ID: 6348867
    [Abstract] [Full Text] [Related]

  • 55. Effect of various oxygenation conditions and fluosol-DA on cytotoxicity and antitumor activity of bleomycin in mice.
    Teicher BA, Holden SA, Cathcart KN, Herman TS.
    J Natl Cancer Inst; 1988 Jun 15; 80(8):599-603. PubMed ID: 2453675
    [Abstract] [Full Text] [Related]

  • 56. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
    Dupuis NP, Kusumoto T, Robinson MF, Liu F, Menon K, Teicher BA.
    Artif Cells Blood Substit Immobil Biotechnol; 1995 Jun 15; 23(3):423-9. PubMed ID: 7493063
    [Abstract] [Full Text] [Related]

  • 57. Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.
    Teicher BA, Bernal SD, Holden SA, Cathcart KN.
    Cancer Chemother Pharmacol; 1988 Jun 15; 21(4):281-5. PubMed ID: 3131032
    [Abstract] [Full Text] [Related]

  • 58. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
    Chaplin DJ, Horsman MR, Siemann DW.
    Br J Cancer; 1993 Aug 15; 68(2):269-73. PubMed ID: 8347481
    [Abstract] [Full Text] [Related]

  • 59. Effects of carbogen plus fractionated irradiation on KHT tumor oxygenation.
    Fenton BM.
    Radiother Oncol; 1997 Aug 15; 44(2):183-90. PubMed ID: 9288848
    [Abstract] [Full Text] [Related]

  • 60. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
    Dorie MJ, Menke D, Brown JM.
    Int J Radiat Oncol Biol Phys; 1994 Jan 01; 28(1):145-50. PubMed ID: 8270435
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.